Guizhou Bailing Ning Tongluo National Projects have gained important progress

On May 23, Guizhou Bailing first disclosed the development of the national-level project of Sugarin Tongluo. Analysis report of the first phase of effectiveness and safety clinical research.

The results showed that in this clinical research trial, the sugar Ningtong Tablets and the only comparison of calcium hydroxytic acid calcium sulfate capsules, which approved the treatment of diabetic retinopathy, showed a more significant efficacy advantage.

Specifically, the best correction vision (BCVA) of patients with diabetic retinopathy can improve the number of patients with diabetic retinopathy and increase the number of letters. Diabetic retinopathy changes in the underground vascular pathology of the diabetic retinopathy, and the overall safety is good. The bottom of the eye shows that the Ganning Tongluo can reduce the microstructure of the bottom of the eye, reduce exudation, thereby reducing microcirculation congestion, and improving microcirculation.

It is understood that in February 2021, the State Administration of Traditional Chinese Medicine issued a notice of the project project of 2021 TCM Science and Technology Research on Science and Technology Research, and the topic of multi -center clinical research and mechanism discussions on the prevention and treatment of diabetes and retinal complications of Ganning Tongluo was officially established. According to the analysis report during the period, as of April 30, a total of 100 subjects in the clinical research group were put into groups, of which 53 were subject to the Sugar Ningtong Tablet. ) 47 cases of treatment had been entered.

The results of the research show that in terms of the main efficacy evaluation indicators, the best correction vision (BCVA) after the treatment time of the treatment of the Ganning Tongluo Table has continued to increase. Correct vision (BCVA) scoring target Eye result is 6.88 points for the sugar Ningtong Tablet group than the baseline. The capsule (Dabing) group increased 6.71 points (P = 0.0304), and the data prompted the treatment of the best correction (BCVA) for the treatment of the best correction (BCVA) for 12 weeks.

The bottom of the eye suggests that the Ganning Tablet tablets can reduce the microbioma of the eyes, reduce exudation, and then reduce microcirculation congestion, and improve microcirculation. In terms of safety, the adverse reactions related to the Ganning Tongluo tablets were not observed, and it was prompted that the Sugarin Tongluo tablets were well used in clinical use.

Jiang Wei, chairman of Guizhou Bailing, said that the results of many years of scientific research and clinical accumulation, the results of the clinical trials of the sugar nets fully meet the expectations. In the past many years, Ganning Tongluo has achieved positive performance in many animal tests and clinical applications. The difference is that in the clinical trials of national scientific research topics, the effective evidence of the effectiveness of the treatment and reverse the complications of the sugar net is obtained again, which is confirmed with the previous research results. Quality, avoiding blindness, and promoting high -quality development of public health are of great significance.

"Through the clinical study of the Sugar.com of the National Project, the relevant clinical data will be collected to evaluate the prevention and treatment effect and safety of the non -proliferation period of the Diabetes retinopathy. Relevant guidelines at home and abroad provide high -quality evidence -based medical evidence. "Jiang Wei said.

Duan Junguo, the leader of the State Administration of Traditional Chinese Medicine, Duan Junguo, the leader of the TCM Ophthalmology Science Department and Dean of the Yinhai Eye Hospital of Chengdu Traditional Chinese Medicine University, pointed out that the control drug "Da Shiming" of this clinical trial is an internationally recognized prevention and treatment of microvascular circulation disorders. drug. In the head -up test with Da Shiming, the overall performance of Ganning Tongluo performed is better than Dabing, and it is also a comprehensive leader in reducing microcirculation congestion, improving the underground microcirculation, and reverse of diabetic retinopathy. It further reflects the unique advantages of Sugarong Tongluo as the treatment of diabetes complications as Chinese medicine. "With the deepening of clinical research on topics, we also look forward to showing better clinical value in the treatment of diabetes and complications in the treatment of diabetes and complications."

In terms of the overall advancement of the Ganning Tongluo project, this variety has been approved and applied to medical institutions in Guizhou Province, Hunan Province, Inner Mongolia, Guangxi and other places, and through the "hospital -enterprise cooperation" model, with the Chinese People's Liberation Army General Hospital, Guangdong, Guangdong, Guangdong Provincial Hospital and Shandong Provincial Hospital and other authoritative hospitals have cooperated with authoritative hospitals. They have deployed 17 provinces and regions and municipalities in the country, and have continuously accumulated clinical data.

In March of this year, the General Office of the State Council issued the "Fourteenth Five -Year Plan" Traditional Chinese Medicine Development Plan. "Planning" has a major reform of Chinese medicine registration and classification, fully adapts to the laws of traditional Chinese medicine research and development, and helps Chinese medicine inheritance and innovation. Among them, the three-combined review system of "Chinese Medicine Theory-Personal Experience-Clinical Test" has provided guidance at the practical level of Chinese medicine transformation through strengthening the study of the study. New drugs such as Fang.

According to the plan, the study of the national -level projects for the study of the Suganin Tongluo series is expected to last for three years. According to Yang Shuyu, the chairman of the Diabetes Branch of the Chinese Medicine Society of the Chinese Medicine Society of the Chinese Medicine Society of the Chinese Medicine Society, introduced that at present, the research of various sub -projects is being progressing smoothly.

Guizhou Daily Tianyan Journalist Du Qiong Jiang Tingting

- END -